Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results

Click here to go back to your search results.

Mesothelioma Cancer treatment details. Chemotherapy. Kinki University School of Medicine, Ohnohigashi, Osakasayama, Japan

Survival: 7.3 months
Toxicity Grade: 5
Treatments: Chemotherapy
Drugs: Pemetrexed
Country: Japan
City/State/Province: Ohnohigashi, Osakasayama
Hospital: Kinki University School of Medicine
Journal: Link
Date: 5/2008

This study involved 25 patients with malignant pleural mesothelioma who had not received prior chemotherapy. Of these, 22 were male, and the median age was 61 years.

Patients in this study were given a combination of cisplatin and pemetrexed, which are chemotherapy agents.

There was one treatment-related death due to worsening of pre-existing pneumonia in this study. Other reported adverse events due to treatment included leukopenia, nausea, and anorexia.

The reported median overall survival was 7.3 months.

This study was funded by Eli Lilly, the makers of pemetrexed (brand name Alimta).

Correspondence: Dr. Kazuhiko Nakagawa; email:

E-mail to a Friend Email Physician More Information